Loading…
BGM Group Ltd. is projected to decline to $0.2732 by 2027, a -3% move from its current price of $0.282. BGM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $0.2664 | $0.2821 | $0.2988 | +0.04% |
| Aug 5 | $0.2602 | $0.2822 | $0.3061 | +0.09% |
| Aug 6 | $0.2556 | $0.2824 | $0.3119 | +0.13% |
| Aug 7 | $0.2518 | $0.2825 | $0.3169 | +0.17% |
| Aug 8 | $0.2486 | $0.2826 | $0.3213 | +0.22% |
| Aug 9 | $0.2456 | $0.2827 | $0.3254 | +0.26% |
| Aug 10 | $0.243 | $0.2829 | $0.3293 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.243 | $0.2829 | $0.3293 | +0.30% |
| Week 2 | $0.2289 | $0.2837 | $0.3517 | +0.61% |
| Week 3 | $0.2187 | $0.2846 | $0.3702 | +0.92% |
| Week 4 | $0.2107 | $0.2855 | $0.3868 | +1.22% |
| Week 5 | $0.2039 | $0.2863 | $0.4021 | +1.53% |
| Week 6 | $0.198 | $0.2872 | $0.4167 | +1.84% |
| Week 7 | $0.1927 | $0.2881 | $0.4306 | +2.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BGM Group Ltd. is a pharmaceutical and chemical company based in Chengdu, China. Through its subsidiaries, it operates in China and offers a range of products across health, agriculture, and traditional medicines, including oxytetracycline products and related active ingredients, licorice extracts and traditional Chinese medicine derivatives, heparin products, sausage casings, and fertilizer products.
It also pursues AI-driven commercialization through the DuXiaoBao platform.
The company’s portfolio includes Qilian Shan oxytetracycline tablets to prevent and treat diseases in chickens, turkeys, cattle, swine, and humans, as well as Qilian Shan oxytetracycline active pharmaceutical ingredients used by manufacturers. In addition, it provides Gan Di Xin licorice medicine, Qilian Shan licorice extract and licorice liquid extract, Ahan antibacterial paste, and various heparin products; sausage casings like Zhu Xiaochang; and Xiongguan organic fertilizers and organic-inorganic compound fertilizers. Overall, the business spans healthcare products, traditional remedies, animal health, and agricultural inputs, with a focus on diversified pharmaceutical and chemical offerings and AI-driven commercialization.
Based in Chengdu, BGM Group Ltd. is categorized in the Healthcare sector and operates across multiple product lines that support both animal and human health, as well as agricultural productivity. This description reflects the range of products and services described in its holdings and the company’s stated focus on AI-enabled platforms for commercialization.
BGM Group Ltd. trades at $0.292 per share and has a market capitalization of $116.98M, with a rank of 4044.
The current price sits in a landscape where near-term forecasts show a mixed path. For 2026, the average price is $0.292 with a 0% ROI, while 2027 shows an average of $0.2818 and a -3.5% ROI. The 2028 and 2029 forecasts point to further declines, with averages of $0.2204 (-24.5% ROI) and $0.229 (-21.6% ROI), respectively.
From 2032 onward, the outlook improves, with 2032 and 2033 averaging $0.3461 and $0.3459 and both carrying 18.5% ROI. The longer horizon strengthens further in 2040 at an average of $0.3975 with a 36.1% ROI, and 2050 at an average of $0.8174 and a 179.9% ROI. The projections include per-year min and max values that illustrate a wide potential range for each year.
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 3.5% below — buyers have tended to step in here.
The nearest ceiling, 33.7% above — a clean break opens room to run.
A major ceiling 109.2% above — clearing it would confirm fresh momentum.
Key BGM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BGM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2822 | Sell | $0.2821 | Sell |
| MA 10 | $0.2848 | Sell | $0.2878 | Sell |
| MA 20 | $0.3043 | Sell | $0.3007 | Sell |
| MA 50 | $0.3265 | Sell | $0.3638 | Sell |
| MA 100 | $0.3876 | Sell | $0.8947 | Sell |
| MA 200 | $2.82 | Sell | $2.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.52 | Neutral |
| Stoch RSI (14) | 66.28 | Neutral |
| CCI (20) | -64.77 | Neutral |
| Williams %R (14) | -75.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -9.32 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 25.00 | Neutral |
| TRIX (15) | -0.65 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 44.54 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.28 | Buy |
| ADX (14) | 12.03 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture shows a bearish sentiment overall.
RSI(14) is 40, suggesting room for downside or consolidation before any clearer uptrend develops. The stock is trading below the SMA50 of $0.327 and well below the SMA200 of $3.35, indicating downside pressure relative to longer-term momentum.
Key near-term levels include a support at $0.29 and a resistance at $0.459. The 30-day price range spans from $0.1798 to $0.4743, and the stock exhibits high annualized volatility at 100%, underscoring the potential for rapid moves in either direction.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.261 | $0.282 | $0.3568 | 0% | Neutral | |
| $0.1991 | $0.2732 | $0.4053 | -3% | Neutral | |
| $0.1495 | $0.2182 | $0.3454 | -23% | Bearish | |
| $0.1396 | $0.2147 | $0.357 | -24% | Bearish | |
| $0.1527 | $0.2464 | $0.4266 | -13% | Neutral | |
| $0.1622 | $0.2735 | $0.4904 | -3% | Neutral | |
| $0.1844 | $0.3244 | $0.5999 | +15% | Neutral | |
| $0.1798 | $0.3294 | $0.6261 | +17% | Neutral | |
| $0.1531 | $0.2917 | $0.5686 | +3% | Neutral | |
| $0.1352 | $0.2679 | $0.5343 | -5% | Neutral | |
| $0.1779 | $0.3953 | $0.867 | +40% | Bullish | |
| $0.3493 | $0.7762 | $1.79 | +175% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.261 | $0.282 | $0.337 | +0.00% |
| September 2026 | $0.2319 | $0.2821 | $0.358 | +0.03% |
| October 2026 | $0.2379 | $0.2934 | $0.3799 | +4.02% |
| November 2026 | $0.2247 | $0.2802 | $0.3687 | -4.50% |
| December 2026 | $0.2121 | $0.2673 | $0.3568 | -4.59% |
Click any year to see its month-by-month BGM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BGM Group Ltd.'s 2026 outlook centres on $0.282, within a $0.261 to $0.3568 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, BGM could reach as high as $0.4053, with a base case around $0.2732 and support toward $0.1991 — roughly -3% from $0.282. Price action looks broadly range-bound.
Expect BGM to range from $0.1495 to $0.3454 through 2028. The $0.2182 average target implies a -23% move from current prices. That is -20% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The BGM price prediction for 2029 points to an average of $0.2147 (low $0.1396, high $0.357) — a potential decline of -24% on today's $0.282. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, BGM is projected to trade between $0.1527 and $0.4266, averaging $0.2464 — a potential decline of -13% from today's $0.282. That is up +15% on the projected 2029 average. A consolidation phase looks the most probable path here.
BGM Group Ltd.'s 2031 outlook centres on $0.2735, within a $0.1622 to $0.4904 range. That is up +11% on the projected 2030 average. That marks a -3% change versus current levels. Price action looks broadly range-bound.
By 2032, BGM could reach as high as $0.5999, with a base case around $0.3244 and support toward $0.1844 — roughly +15% from $0.282. A consolidation phase looks the most probable path here.
Expect BGM to range from $0.1798 to $0.6261 through 2033. The $0.3294 average target implies a +17% move from current prices. That is up +2% on the projected 2032 average. Price action looks broadly range-bound.
The BGM price prediction for 2034 points to an average of $0.2917 (low $0.1531, high $0.5686) — a potential gain of +3% on today's $0.282. A consolidation phase looks the most probable path here.
In 2035, BGM is projected to trade between $0.1352 and $0.5343, averaging $0.2679 — a potential decline of -5% from today's $0.282. That is -8% versus the projected 2034 average. Price action looks broadly range-bound.
BGM Group Ltd.'s 2040 outlook centres on $0.3953, within a $0.1779 to $0.867 range. That is up +48% on the projected 2035 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, BGM could reach as high as $1.79, with a base case around $0.7762 and support toward $0.3493 — roughly +175% from $0.282. Momentum favours further upside here.
Investing $1,000 in BGM today (≈ 3,546.099291 BGM) could be worth
$2,752.64
+$1,752.64 (+175%) by 2050 · US Dollar
Based on the average projected BGM price of $0.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BGMwould be worth at today's price.
$1,000 invested in BGM on Jul 31, 2025 (≈ 118.203309 BGM) would be worth
$33.33
-$966.67 (-96.7%) today · 0.03× · US Dollar
Based on a BGM entry price of $8.46 vs. today's $0.282.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.29 | $972.41 | -2.8% |
| 1 month ago | $0.364 | $774.73 | -22.5% |
| 3 months ago | $0.301 | $936.88 | -6.3% |
| 6 months ago | $2.94 | $95.92 | -90.4% |
| 1 year ago | $8.46 | $33.33 | -96.7% |
| All time (5.0y) ago | $21.1 | $13.36 | -98.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BGM forecast.
Our base-case forecast reaches $0.56 around 2050.
Implied market cap at $0.56: $213.15M
The multi-year forecast paints a path from muted to negative returns in the early years, with a turning point toward modest upside in the early 2030s and stronger gains by the mid-to-late decade.
The 2026–2029 period shows flat to negative momentum, with 2026 averaging $0.292 (ROI 0%), and 2027–2029 averaging $0.2818, $0.2204, and $0.229 respectively, and negative ROIs ranging from -3.5% to -24.5%. In 2032–2033, the average prices rise to about $0.3461 and $0.3459 with an 18.5% ROI, signaling a shift toward positive momentum.
The long-term view strengthens considerably by 2040 and 2050, with 2040 averaging $0.3975 and a 36.1% ROI, and 2050 averaging $0.8174 with a 179.9% ROI. These figures imply substantial upside potential in the distant horizon, though they come with inherent uncertainty and are not guarantees.
Tap a question to reveal the answer.
The forecast shows an average price of $0.2578 with a min of $0.1595 and a max of $0.4472, and a ROI of -11.7%. The sentiment is Neutral.
Near term shows neutral to bearish signals (2026 avg $0.292, ROI 0%; 2027–2029 negative ROIs), but longer-term upside is indicated with 2032–2033 ROIs at 18.5% and 2040/2050 ROIs of 36.1% and 179.9%, respectively.
Yes. The max values reach as high as $0.6583 (2033) and $0.8723 (2040), with a long-term max of $1.88 in 2050.
Current price is $0.292 and market cap is $116.98M. The rank is 4044.
30-day range low is $0.1798 and high is $0.4743.
BGM Group Ltd. Community Discussion
0Share your BGM Group Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.